Sphingosine 1-phosphate receptor 1 regulates cell-surface localization of membrane proteins in endothelial cells

• Published in: Biochimica et biophysica acta. General subjects Vol. 1863; no. 6; pp. 1079 - 1087
• Main Authors: Shi, Xulai, Wang, Wanshan, Li, Jia, Wang, Ting, Lin, Yan, Huang, Siqi, Kuver, Aarti, Chen, Chengshui, Hla, Timothy, Li, Xi, Dai, Kezhi
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.06.2019
• Subjects: animal models; Animals; biotinylation; Cell Line; Cell Membrane - genetics; Cell Membrane - metabolism; chromatography; computer software; edema; Endoglin - genetics; Endoglin - metabolism; endothelial cells; Endothelial Cells - cytology; Endothelial Cells - metabolism; Gene Expression Regulation; membrane proteins; Mice; Mice, Knockout; Models, Biological; phenotype; proteomics; sphingosine; Sphingosine-1-Phosphate Receptors - genetics; Sphingosine-1-Phosphate Receptors - metabolism; tandem mass spectrometry; therapeutics; Western blotting
• ISSN: 0304-4165; 1872-8006; 1872-8006
• DOI: 10.1016/j.bbagen.2019.04.001

The endothelial cell (EC) barrier disruption has been implicated in vascular leakage and pulmonary edema. Many reports have shown that the EC barrier dysfunction is regulated by the sphingosine-1-phophate (S1P)/S1P receptor-1 (S1PR1) axis. Identifying downstream effectors for the S1P/S1PR1 axis in pulmonary vasculature has been limited by mixed populations in vitro cultures that do not retain physiological EC phenotype and complex of tedious proteomics. In this study, we used a combination of in vivo biotinylation and liquid chromatograph tandem mass spectrometry on three mouse models of S1pr1 expression, namely normal, knockout (KO) and high, to identify EC membrane proteins whose cell-surface expression is S1pr1-dependent. EC-specific KO of S1pr1 caused severe pulmonary vascular disruption and reduction of many membrane proteins on ECs. Using the MaxQuant software we were able to identify novel membrane targets of S1pr1, for instance, Cd105 and Plvap, by comparison with their membrane expressions among the three EC model systems. Moreover, regulation of Cd105 and Plvap by S1pr1 were validated with Western blot and immunostaining in vivo and in vitro. Our data suggest that S1pr1 dictates cell-surface localization of several apical membrane proteins in ECs. Our results are insightful for development of novel therapeutics to specifically target EC barrier function. •Isolation of EC surface proteins from mouse pulmonary vasculature for LC-MS/MS•Identification of putative S1pr1 targets in mouse models with different expression of S1pr1•Validation of CD105 and PLVAP as endothelial cell-surface targets of S1PR1